Can selected Borrelia IgM reactivity reflect recent antigen recognition?

In an 83-year-old man, the clinical timing, exposure history, manifestations, and full testing algorithm are more informative than an isolated Borrelia IgM result. IgM serology reflects an antibody response, not a direct measure of viable organisms or ongoing infection.

Clinical interpretation

• In compatible illness of ≤30 days, a positive IgM within recommended standard or modified two-tier testing can support recent Borrelia antigen recognition. It remains conditional evidence rather than proof of active disease or a precise infection date.
• Early negative serology does not exclude infection: a systematic review/meta-analysis found two-tier sensitivity of 46.3% in early localized disease. If suspicion is high at an early stage, repeat testing after 7–14 days may identify IgG seroconversion.
• After >30 days of symptoms, CDC guidance advises disregarding IgM and relying on IgG interpreted through the complete two-tier algorithm. A reactive screening assay alone is insufficient.

Cross-reactivity and persistence

• False or isolated IgM reactivity is well documented. Potential cross-reactive settings include Epstein–Barr virus (EBV), syphilis, relapsing fever, and rheumatoid arthritis; certain immunoblot targets, including p41 flagellin, are particularly susceptible.
• In active EBV infection, positive/borderline Lyme IgM frequencies ranged from 11.1% by immunoblot to 51.9% by immunofluorescence. In referral practice, 27.5% of IgM immunoblots were false positive; another multicenter analysis found over half met its false-positive definition.
• IgM can persist for months to years after resolved or successfully treated infection. Thus, persistent reactivity cannot distinguish prior exposure from current infection.

Mechanistic and clinical implications

• Cross-reactive antibodies generated by unrelated infections or autoimmune disease can bind Lyme-assay antigens, while durable humoral immune responses can maintain detectable IgM after clearance.
• Bottom line: Selected early, algorithm-confirmed IgM may support recent antigen recognition, but isolated or persistent IgM—especially in late illness—should not independently be taken as evidence of ongoing active Borrelia infection.